Big Pharma backs EU antibiotic R&D plan, Pfizer prompts Karo cuts, Advent closes £146M fund

Nick Paul Taylor

In this week's EuroBiotech Report, a who's who of Big companies joined a European public-private consortium to develop and test new economic models of R&D with the goal of making R&D economically attractive again. And more.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS